Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5276952
Max Phase: Preclinical
Molecular Formula: C98H172N26O22S
Molecular Weight: 2098.68
Associated Items:
ID: ALA5276952
Max Phase: Preclinical
Molecular Formula: C98H172N26O22S
Molecular Weight: 2098.68
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](N)Cc2ccc(cc2)OCCSC[C@@H](C(=O)NCC(=O)O)NC1=O
Standard InChI: InChI=1S/C98H172N26O22S/c1-19-55(14)76-92(141)117-70(45-54(12)13)91(140)121-77(56(15)20-2)94(143)119-72(83(132)109-48-75(128)129)50-147-41-40-146-61-33-31-60(32-34-61)46-62(100)81(130)111-64(28-24-25-37-99)85(134)113-66(35-36-73(101)126)87(136)115-69(44-53(10)11)90(139)122-79(58(17)22-4)95(144)124-80(59(18)23-5)96(145)123-78(57(16)21-3)93(142)116-67(42-51(6)7)88(137)118-71(49-125)82(131)108-47-74(127)110-63(29-26-38-106-97(102)103)84(133)112-65(30-27-39-107-98(104)105)86(135)114-68(43-52(8)9)89(138)120-76/h31-34,51-59,62-72,76-80,125H,19-30,35-50,99-100H2,1-18H3,(H2,101,126)(H,108,131)(H,109,132)(H,110,127)(H,111,130)(H,112,133)(H,113,134)(H,114,135)(H,115,136)(H,116,142)(H,117,141)(H,118,137)(H,119,143)(H,120,138)(H,121,140)(H,122,139)(H,123,145)(H,124,144)(H,128,129)(H4,102,103,106)(H4,104,105,107)/t55-,56-,57-,58-,59-,62+,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,76-,77-,78-,79-,80-/m0/s1
Standard InChI Key: VSAKNEQOIGSEFP-RASBGUIFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2098.68 | Molecular Weight (Monoisotopic): 2097.2860 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Iyamu ID, Huang R.. (2021) Mechanisms and inhibitors of nicotinamide N-methyltransferase., 12 (8.0): [PMID:34458733] [10.1039/D1MD00016K] |
Source(1):